Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
national top stories
roche
boston
boston blog main
boston top stories
clinical trials
deals
europe top stories
fda
genentech
san francisco top stories
avapritinib
billy dunn
biogen
biopharma
blueprint medicines
cstone pharmaceuticals
drug prices
drug pricing
duchenne
eli lilly
europe blog main
european medicines agency
evrysdi
fisogatinib
flatiron health
gene therapy
hepatocellular carcinoma
investing
ionis pharmaceuticals
jeff albers
licensing
m&a
medullary thyroid cancer
muscular dystrophy
national
new york top stories
What
fda
3
×
roche
3
×
approval
drug
medicine
therapy
approved
atrophy
betting
billion
biopharma
blueprint
cancer
candidate
currently
daily
deal
duchenne
evrysdi
friday
gene
green
historic
home
intended
lights
liquid
marketing
medicines
muscle
muscular
new
oral
pact
patients
puts
recently
regulatory
ret
review
Language
unset
Current search:
biotech
×
fda
×
roche
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal